# Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat

> **NCT00402987** · PHASE3 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 269 (actual)

## Conditions studied

- Pharyngitis

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Celecoxib
- **DRUG:** celecoxib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00402987
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12-04
- **Primary completion:** 2007-11-15
- **Final completion:** 2007-11-15
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402987, "Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00402987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*